Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · IEX Real-Time Price · USD
16.93
+0.03 (0.18%)
At close: May 31, 2024, 4:00 PM
16.89
-0.04 (-0.24%)
After-hours: May 31, 2024, 7:52 PM EDT

Teva Pharmaceutical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 2000
Revenue
15,84614,92515,87816,65916,887
Upgrade
Revenue Growth (YoY)
6.17%-6.00%-4.69%-1.35%-7.57%
Upgrade
Cost of Revenue
8,2007,9528,2848,9339,351
Upgrade
Gross Profit
7,6466,9737,5947,7267,536
Upgrade
Selling, General & Admin
3,4983,4453,5283,6713,806
Upgrade
Research & Development
9538389679971,010
Upgrade
Other Operating Expenses
2,7624,8871,3846,6293,164
Upgrade
Operating Expenses
7,2139,1705,87911,2977,980
Upgrade
Operating Income
433-2,1971,715-3,571-444
Upgrade
Interest Expense / Income
1,0579661,058834822
Upgrade
Other Expense / Income
-58-7429-24711
Upgrade
Pretax Income
-566-3,089628-4,158-1,277
Upgrade
Income Tax
-7-643211-168-278
Upgrade
Net Income
-559-2,446417-3,990-999
Upgrade
Shares Outstanding (Basic)
1,1191,1101,1021,0951,091
Upgrade
Shares Outstanding (Diluted)
1,1191,1101,1071,0951,091
Upgrade
Shares Change
0.81%0.27%1.10%0.37%6.86%
Upgrade
EPS (Basic)
-0.50-2.200.38-3.64-0.91
Upgrade
EPS (Diluted)
-0.50-2.200.38-3.64-0.91
Upgrade
Free Cash Flow
8421,042236638223
Upgrade
Free Cash Flow Per Share
0.750.940.210.580.20
Upgrade
Gross Margin
48.25%46.72%47.83%46.38%44.63%
Upgrade
Operating Margin
2.73%-14.72%10.80%-21.44%-2.63%
Upgrade
Profit Margin
-3.53%-16.39%2.63%-23.95%-5.92%
Upgrade
Free Cash Flow Margin
5.31%6.98%1.49%3.83%1.32%
Upgrade
Effective Tax Rate
--33.60%--
Upgrade
EBITDA
1,644-8153,016-1,7671,267
Upgrade
EBITDA Margin
10.37%-5.46%18.99%-10.61%7.50%
Upgrade
Depreciation & Amortization
1,1531,3081,3301,5571,722
Upgrade
EBIT
491-2,1231,686-3,324-455
Upgrade
EBIT Margin
3.10%-14.22%10.62%-19.95%-2.69%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).